Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin Type A for Allodynic Neuropathic Pain in SCI or MS
NCT01911377Phase 2Terminated
- Sponsor
- University of Manitoba
- Start
- Oct 2013
- Primary completion
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in neuropathic pain, allodynia, sponsored by University of Manitoba. Started Oct 2013; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
neuropathic painallodynia
Beyond the preview
Go deeper on NCT01911377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01911377.